BRIEF published on 04/01/2025 at 07:20, 1 year 5 months ago Eurofins Completes Acquisition of SYNLAB's Spanish Operations Healthcare Expansion Laboratory Services Clinical Diagnostics Eurofins Acquisition SYNLAB Spain
BRIEF published on 04/01/2025 at 07:20, 1 year 5 months ago Eurofins finalise l'acquisition des activités espagnoles de SYNLAB Expansion Des Soins De Santé Diagnostic Clinique Acquisition D'Eurofins SYNLAB Espagne Services De Laboratoire
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Adval Tech Announces Strategic Direction and Board Changes Board Changes Strategy SIX Swiss Exchange Adval Tech Market Positioning
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Adval Tech annonce une orientation stratégique et des changements au sein du conseil d'administration Stratégie SIX Swiss Exchange Adval Tech Changements Au Conseil D'administration Positionnement Sur Le Marché
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago La branche hôtelière d'AEVIS VICTORIA affiche une forte croissance en 2024 Performance Financière Investissement Immobilier AEVIS VICTORIA Croissance Hôtelière Michel Reybier Hospitality
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago AEVIS VICTORIA's hotel branch shows strong growth in 2024 Real Estate Investment Financial Performance AEVIS VICTORIA Michel Reybier Hospitality Hotel Growth
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Lonza Completes its CHF 2 Billion Share Buyback Program Share Buyback Lonza Financial Strategy Swiss Exchange CHF 2 Billion
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Lonza finalise son programme de rachat d'actions de 2 milliards de francs suisses Rachat D'actions Lonza Stratégie Financière Bourse Suisse 2 Milliards De Francs Suisses
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Newron Pharmaceuticals Reports 2024 Financial Results, Previews 2025 Financial Results Evenamide Development Schizophrenia Treatment Licensing Agreements Outlook 2025
BRIEF published on 04/01/2025 at 07:05, 1 year 5 months ago Newron Pharmaceuticals publie ses résultats financiers pour 2024 et présente un aperçu de 2025. Résultats Financiers Développement D'Evenamide Traitement De La Schizophrénie Accords De Licence Perspectives 2025
Published on 09/14/2026 at 15:15, 2 hours 3 minutes ago Mako Mining Announces a Non-Binding Letter of Intent to Enter a Gold Purchase Agreement with Sailfish Royalty to Lower its Cost of Capital and Facilitate Shareholder Returns and Accretive Acquisitions
Published on 09/14/2026 at 15:00, 2 hours 18 minutes ago Vox Royalty Completes Acquisitions of White Dam, Kalman and Sylvania Australian Gold & Copper Royalties
Published on 09/14/2026 at 14:30, 2 hours 48 minutes ago Goldcliff Finalizes Drill Plans for New East Breccia Gold-Silver Target at Kettle Valley
Published on 09/14/2026 at 14:00, 3 hours 18 minutes ago Revolve Completes Acquisition of 9.6 MW Operating Wind Project in the US
Published on 09/14/2026 at 14:00, 3 hours 18 minutes ago Kinross Encounters Gold and Copper in Recent Drill Holes with Gold Values up to 6 g/t, Kinross Drilling to Continue on Dixie Halo
Published on 09/14/2026 at 17:05, 13 minutes ago KHLOÉ KARDASHIAN ANNOUNCES RETAIL EXPANSION INTO SEPHORA WITH HER GLOBALLY ACCLAIMED FRAGRANCE PORTFOLIO WITH LUXE BRANDS
Published on 09/14/2026 at 17:00, 18 minutes ago EQS-Adhoc: Fourcore Tech Finance Ltd.: Update on capital structure realignment and timing of September 2026 interest payments
Published on 09/14/2026 at 16:52, 26 minutes ago BERENBERG initiates coverage and recommends buying 2G Energy share
Published on 09/14/2026 at 16:35, 43 minutes ago Neolix Joins Espaces-Mobilités and Stalem to Pilot L4 Autonomous RoboVans in Brussels
Published on 09/14/2026 at 16:00, 1 hour 18 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 09/14/2026 at 16:15, 1 hour 3 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of August 31, 2026
Published on 09/14/2026 at 16:15, 1 hour 3 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 août 2026
Published on 09/11/2026 at 07:00, 3 days 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
